Reproducibility of mRNA-Based Testing of ESR1, PGR, ERBB2, and MKI67 Expression in Invasive Breast Cancer—A Europe-Wide External Quality Assessment

SIMPLE SUMMARY: Four biomarkers [estrogen receptor (ER), progesterone receptor (PgR), Ki-67, and HER2], are used to stratify breast cancer (BC) into subtypes predictive of therapy response. In a Europe-wide external quality assessment, we compared performance of an mRNA-based method [Xpert(®) Breast...

Descripción completa

Detalles Bibliográficos
Autores principales: Erber, Ramona, Hartmann, Arndt, Fasching, Peter Andreas, Ruebner, Matthias, Stöhr, Robert, Beckmann, Matthias Wilhelm, Zentgraf, Miriam, Popp, Verena, Weidler, Jodi, Simon, Iris, Becker, Steffi, Huebner, Hanna, Fischer, Josephine, Guerini Rocco, Elena, Viale, Giuseppe, Cayre, Anne, Penault-Llorca, Frederique, Caniego Casas, Tamara, Pérez-Miés, Belén, Palacios, José, Jank, Paul, Denkert, Carsten, Khoury, Lina, Mairinger, Thomas, Ferrazzi, Fulvia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8470348/
https://www.ncbi.nlm.nih.gov/pubmed/34572945
http://dx.doi.org/10.3390/cancers13184718

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8470348/
https://www.ncbi.nlm.nih.gov/pubmed/34572945
http://dx.doi.org/10.3390/cancers13184718

Ejemplares similares